News

Sun Pharma announced the launch of BromSite™ (bromfenac ophthalmic solution) 0.075% in the US market.A nonsteroidal anti-inflammatory drug indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery.  ...

WIN INDIA 2016, India’s leading industrial and engineering trade fair will bring together 3 key industrial trade fairs - CeMAT INDIA, Industrial Automation INDIA (IA India) and Motion Drive & Automation INDIA (MDA India). The events...

UBM India, India's leading exhibition organizer, is all set to host CPhI & P-MEC India 2016, one of the world’s leading pharmaceutical networking event in Mumbai. In its tenth anniversary, the expo is slated to transform...

Biothera Pharmaceuticals Inc will present new preclinical data that further validate the ability of its Phase 2 cancer immunotherapy drug Imprime PGG to induce coordinated innate and adaptive immune responses that may enhance the efficacy of checkpoint inhibitor therapies....

Allergan plc a leading global pharmaceutical company announced the availability of TAYTULLA™ (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1mg/20mcg, the first and only oral contraceptive in a softgel capsule for the prevention of pregnancy. ...

Gilead Sciences Inc announced that the U.S. FDA has approved Vemlidy® (tenofovir alafenamide, TAF) 25mg, a once-daily treatment for adults with chronic hepatitis B virus (HBV) infection with compensated liver disease.   Vemlidy has a boxed...

Mallinckrodt Pharmaceuticals a leading global specialty pharmaceutical company, will present on Wednesday, Nov. 30, 2016, at the 28th Annual Piper Jaffray Healthcare Conference at the Lotte New York Palace, 455 Madison Ave, New York. Matthew Harbaugh,...